SHEILA MAIER: Open Payments
NPI 1033599162 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 31 payments from 15 companies in 2025. Trend: 2023 $486 · 2024 $977 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $190 |
| Abbott Laboratories | 4 | $111 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Janssen Biotech, Inc. | 1 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Novo Nordisk Inc | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
Products named: FREESTYLE LIBRE 3, EVENITY, BENLYSTA, RECORLEV, ORENCIA, Kerendia, TREMFYA, MOUNJARO.
Industry payments across CO — which companies pay providers there.
